Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Huttner
Stephan Harbarth

Showing results (301-310 of 501) with videos related to

Pageof 51
Sort By:
Critical Care (London, England)|April 10, 2014
Multilevel competing risk models to evaluate the risk of nosocomial infectionMartin Wolkewitz, Ben S Cooper, Mercedes Palomar-Martinez, et al.
International Journal of Antimicrobial Agents|March 11, 2017
Erratum to 'Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae' [International Journal of Antimicrobial Agents 49/1 67-73]Jean-Ralph Zahar, Philippe Lesprit, Stephane Ruckly, et al.
Antimicrobial Resistance and Infection Control|January 29, 2022
High adherence to national IPC guidelines as key to sustainable VRE control in Swiss hospitals: a cross-sectional surveyDanielle Vuichard-Gysin, Rami Sommerstein, Andreas Kronenberg, et al.
Ebiomedicine|September 7, 2021
Effects of antibiotic duration on the intestinal microbiota and resistome: The PIRATE RESISTANCE project, a cohort study nested within a randomized trialStefano Leo, Vladimir Lazarevic, Elodie von Dach, et al.
Critical Care (London, England)|November 23, 2021
The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance studyLauro Damonti, Andreas Kronenberg, Jonas Marschall, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 24, 2023
Catheter size and risk of short-term peripheral venous catheter-associated bloodstream infections: an observational studyMatteo Faltoni, Gaud Catho, Eva Pianca, et al.
The Journal of Antimicrobial Chemotherapy|July 18, 2025
Horizontal transmission of a multidrug-resistant IncM1 plasmid harbouring blaOXA-48 and blaCTX-M-14b among patient microbiotasRoberto Sierra, Mélanie Roch, Julien Prados, et al.
The Lancet. Infectious Diseases|February 28, 2017
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trialAngela Huttner, Christoph Hatz, Germie van den Dobbelsteen, et al.
The Lancet. Infectious Diseases|November 6, 2017
Surveillance for control of antimicrobial resistanceEvelina Tacconelli, Frangiscos Sifakis, Stephan Harbarth, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2020
Risk of MS relapse after yellow fever vaccination: A self-controlled case seriesAngela Huttner, Gilles Eperon, Agustina M Lascano, et al.
Pageof 51

Showing results (301-310 of 501) with videos related to

Sort By:
Pageof 51
Critical Care (London, England)|April 10, 2014
Multilevel competing risk models to evaluate the risk of nosocomial infectionMartin Wolkewitz, Ben S Cooper, Mercedes Palomar-Martinez, et al.
International Journal of Antimicrobial Agents|March 11, 2017
Erratum to 'Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae' [International Journal of Antimicrobial Agents 49/1 67-73]Jean-Ralph Zahar, Philippe Lesprit, Stephane Ruckly, et al.
Antimicrobial Resistance and Infection Control|January 29, 2022
High adherence to national IPC guidelines as key to sustainable VRE control in Swiss hospitals: a cross-sectional surveyDanielle Vuichard-Gysin, Rami Sommerstein, Andreas Kronenberg, et al.
Ebiomedicine|September 7, 2021
Effects of antibiotic duration on the intestinal microbiota and resistome: The PIRATE RESISTANCE project, a cohort study nested within a randomized trialStefano Leo, Vladimir Lazarevic, Elodie von Dach, et al.
Critical Care (London, England)|November 23, 2021
The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance studyLauro Damonti, Andreas Kronenberg, Jonas Marschall, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 24, 2023
Catheter size and risk of short-term peripheral venous catheter-associated bloodstream infections: an observational studyMatteo Faltoni, Gaud Catho, Eva Pianca, et al.
The Journal of Antimicrobial Chemotherapy|July 18, 2025
Horizontal transmission of a multidrug-resistant IncM1 plasmid harbouring blaOXA-48 and blaCTX-M-14b among patient microbiotasRoberto Sierra, Mélanie Roch, Julien Prados, et al.
The Lancet. Infectious Diseases|February 28, 2017
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trialAngela Huttner, Christoph Hatz, Germie van den Dobbelsteen, et al.
The Lancet. Infectious Diseases|November 6, 2017
Surveillance for control of antimicrobial resistanceEvelina Tacconelli, Frangiscos Sifakis, Stephan Harbarth, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2020
Risk of MS relapse after yellow fever vaccination: A self-controlled case seriesAngela Huttner, Gilles Eperon, Agustina M Lascano, et al.
Pageof 51